Press release
Myopia Market is expected to reach USD 37.6 billion by 2034
Myopia, or nearsightedness, is the most common refractive error globally, where distant objects appear blurry while near vision remains clear. It occurs when the eyeball is too long or the cornea has excessive curvature, causing light to focus in front of the retina.Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72293
The condition has reached epidemic levels in many regions, especially in Asia, where lifestyle factors such as increased screen time, reduced outdoor activities, and intensive educational practices have accelerated its prevalence. With over 2.6 billion people worldwide affected in 2024, myopia poses a significant public health and economic burden.
The market is driven by the rising demand for corrective eyewear, contact lenses, surgical procedures (LASIK, SMILE), and advanced myopia management therapies for children.
Market Overview
• Market Size (2024): USD 18.4 billion
• Forecast (2034): USD 37.6 billion
• CAGR (2025-2034): 7.4%
Key Highlights:
• Myopia prevalence projected to affect nearly 50% of the global population by 2050.
• Strong demand for eyeglasses and contact lenses continues, but surgical options are expanding.
• Rapid adoption of myopia control therapies (orthokeratology, atropine drops, multifocal lenses) in children.
• Growing e-commerce penetration for eyewear sales.
Segmentation Analysis
By Correction Type:
• Eyeglasses (largest share)
• Contact Lenses
o Soft Contact Lenses
o Rigid Gas Permeable (RGP) Lenses
o Orthokeratology (Ortho-K)
• Refractive Surgery
o LASIK
o PRK
o SMILE
• Myopia Control Therapies
o Atropine Eye Drops
o Multifocal Contact Lenses
o Specialty Spectacle Lenses
By Age Group:
• Pediatric (fastest-growing, due to myopia control adoption)
• Adult
• Geriatric
By Distribution Channel:
• Optical Stores
• Hospitals & Specialty Clinics
• Ambulatory Surgical Centers
• Online Retail
Segmentation Summary:
Eyeglasses dominate the global market, but pediatric myopia management solutions represent the fastest-growing category, as early intervention is critical to slowing progression.
Explore Full Report here: https://exactitudeconsultancy.com/reports/72293/myopia-market
Regional Analysis
North America
• ~38% share in 2024.
• High demand for refractive surgeries and premium corrective lenses.
• Rising pediatric myopia management adoption.
Europe
• ~29% share.
• Germany, France, and the UK leading in premium eyewear and refractive procedures.
• Growing awareness of childhood myopia prevention.
Asia-Pacific
• Fastest-growing region, CAGR ~8.8%.
• Highest prevalence, with China, Japan, South Korea, and Singapore showing near epidemic levels.
• Strong adoption of myopia control therapies and e-commerce eyewear platforms.
Latin America
• Brazil and Mexico driving market expansion, supported by optical retail chains.
Middle East & Africa
• GCC countries advancing in refractive surgery adoption.
• Unmet need in rural areas due to low access to vision care.
Regional Summary:
Asia-Pacific leads in patient volume and fastest growth, while North America and Europe dominate technology adoption and premium products.
Market Dynamics
Key Growth Drivers:
• Rising global prevalence of myopia, particularly among children.
• Increasing awareness of preventive myopia management.
• Expanding e-commerce and digital eye care platforms.
• Technological innovation in lenses, refractive surgery, and diagnostics.
Key Challenges:
• High cost of refractive surgeries.
• Limited access to advanced myopia management therapies in low-income regions.
• Risk of surgical complications (regression, dry eye, halos).
• Growing dependence on digital devices fueling prevalence.
Latest Trends:
• Expansion of orthokeratology lenses for slowing pediatric myopia progression.
• Use of low-dose atropine therapy gaining regulatory approvals.
• Integration of AI-powered refraction and tele-optometry services.
• Fashion-driven demand for premium eyewear brands.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72293
Competitor Analysis
Major Players in the Market:
• EssilorLuxottica SA (eyeglasses, specialty lenses for myopia control)
• Johnson & Johnson Vision Care (Acuvue contact lenses, myopia control research)
• Alcon Inc. (contact lenses, surgical devices)
• Bausch + Lomb
• Carl Zeiss Meditec AG (refractive surgery systems, lenses)
• Hoya Corporation (MiYOSMART spectacle lenses for myopia management)
• CooperVision, Inc. (MiSight contact lenses for myopia control)
• STAAR Surgical Company (implantable collamer lenses)
• Menicon Co., Ltd. (Ortho-K lenses)
• Topcon Corporation (diagnostic imaging devices)
Competitive Summary:
EssilorLuxottica, Hoya, and CooperVision lead the pediatric myopia management segment. Alcon, Zeiss, and STAAR Surgical dominate refractive surgery devices, while Johnson & Johnson and Bausch + Lomb strengthen their lens portfolios. The competitive landscape is defined by innovation, affordability, and strong retail distribution.
Conclusion
The Myopia Market, valued at USD 18.4 billion in 2024, is projected to reach USD 37.6 billion by 2034, expanding at a CAGR of 7.4%.
Key Takeaways:
• Eyeglasses dominate, but pediatric myopia management is the fastest-growing segment.
• North America and Europe lead in premium technologies, while Asia-Pacific grows fastest due to high prevalence.
• Advances in AI diagnostics, myopia control therapies, and online distribution are reshaping the industry.
• Long-term opportunities lie in integrating preventive strategies with lifestyle-driven solutions.
Over the next decade, the myopia market will transition from conventional correction toward preventive, personalized, and technology-driven solutions, aiming to slow the epidemic's growth and improve global eye health.
This report is also available in the following languages : Japanese (近視市場), Korean (근시 시장), Chinese (近视市场), French (Marché de la myopie), German (Myopie-Markt), and Italian (Mercato della miopia), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/72293/myopia-market#request-a-sample
Our More Reports:
AI in Medical Imaging Market
https://exactitudeconsultancy.com/reports/73715/ai-in-medical-imaging-market
Collaborative Robot Market
https://exactitudeconsultancy.com/reports/73716/collaborative-robot-market
AI in Clinical Trials Market
https://exactitudeconsultancy.com/reports/73717/ai-in-clinical-trials-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Myopia Market is expected to reach USD 37.6 billion by 2034 here
News-ID: 4193946 • Views: …
More Releases from Exactitude Consultancy

Granulomatosis with Polyangiitis Market Projected to Grow at 7.0% CAGR, Reaching …
Introduction
Granulomatosis with polyangiitis (GPA), formerly known as Wegener's granulomatosis, is a rare autoimmune disorder characterized by inflammation of small to medium-sized blood vessels. The disease typically affects the respiratory tract, kidneys, and other organs, leading to granuloma formation and potentially life-threatening complications.
While GPA is rare, timely diagnosis and treatment are critical to improving patient outcomes. Advances in immunosuppressive therapies, biologics, and targeted treatments have transformed disease management in recent years.…

X-Linked Retinitis Pigmentosa Market Set to Grow at 11.0% CAGR, Reaching USD 890 …
Introduction
X-linked retinitis pigmentosa (XLRP) is a rare, inherited retinal disorder characterized by progressive degeneration of the photoreceptor cells, leading to night blindness, tunnel vision, and eventual loss of sight. Affecting primarily males, XLRP is one of the most severe forms of retinitis pigmentosa, with onset typically in childhood or adolescence. While supportive care and assistive technologies have been the traditional means of management, the rise of gene therapy and regenerative…

Rhino-Conjunctivitis Market Forecast to Grow at 6.5% CAGR, Reaching USD 17.0 Bil …
Introduction
Rhino-conjunctivitis, an inflammatory condition combining allergic rhinitis (nasal symptoms) and allergic conjunctivitis (ocular symptoms), is one of the most common allergic disorders worldwide. Patients often experience sneezing, nasal congestion, watery eyes, and itching, leading to reduced quality of life, sleep disturbance, and productivity loss. The condition affects children and adults alike and is often linked to seasonal allergens such as pollen or perennial triggers like dust mites and pet dander.
Growing…

Retinal Neovascularization Market Expected to Grow at 6.6% CAGR, Reaching USD 19 …
Introduction
Retinal neovascularization is a pathological process characterized by the abnormal growth of new blood vessels in the retina, often associated with diseases such as diabetic retinopathy, retinal vein occlusion, and age-related macular degeneration. These fragile vessels can leak blood or fluid, leading to macular edema, scarring, and potentially permanent vision loss. As diabetes prevalence rises globally and populations age, retinal neovascularization has become a growing concern in ophthalmology and public…
More Releases for Myopia
Myopia Control Lenses Market Forecast to Expand at 16.2% CAGR Amid Increasing Pe …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Myopia Control Lenses Market- (By Lens Type (Multifocal Lenses, Orthokeratology Lenses, Dual-Focus Lenses, Peripheral Defocus Lenses), By Age Group (Children, Adults), By Distribution Channel (Optometry Clinics, Optical Retail Stores, Online Retail)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the Global Myopia Control Lenses Market is valued…
Myopia Control Lenses Market Size to Grow with Rising Prevalence of Childhood My …
The latest Myopia Control Lenses Market research report offers crucial insights into how the industry is evolving, highlighting key drivers of growth and the main revenue streams expected between 2025 and 2032. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The Industry compass guiding business through the complexities of the market, presenting not only the current landscape but also the latest innovations shaping its…
Latest Trends In Myopia Treatment Devices Market
A cutting-edge solution to the problem of myopia or nearsightedness is a wearable gadget for myopia control.
These tools, which frequently come in the shape of smart glasses or specialised contact lenses, make use of cutting-edge technology to control and slow the growth of myopia.
Wearable myopia control devices offer a proactive method of maintaining eye health by utilising features like changeable focus, customised vision correction, and real-time monitoring.
Request…
Myopia Control Devices Market - Seeing Beyond Blur: Revolutionary Myopia Devices …
Newark, New Castle, USA: The "Myopia Control Devices Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Myopia Control Devices Market: https://www.growthplusreports.com/report/myopia-control-devices-market/7989
This latest report researches the industry structure,…
Myopia Control Devices Market - Unlocking the Future of Clear Sight: Myopia Cont …
Newark, New Castle, USA - new report, titled Myopia Control Devices Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Myopia Control Devices market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Myopia Control Devices market. The report offers an overview of…
The Myopia Market is expected to be driven by the factors such as the rising cas …
The Myopia market is expected to show positive growth, mainly attributed to the increased diagnosed prevalence and also, the launch of upcoming devices during the forecast period. Moreover, advances in disease mechanisms have yielded new diagnostic and treatment approaches, opening avenues to better treatment interventions.
The Myopia market report provides current treatment practices, emerging drugs, Myopia market share of the individual therapies, current and forecasted Myopia market Size from 2019 to…